CC
RVMD icon

Corton Capital’s Revolution Medicines RVMD Stock Holding History

Corton Capital’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$328K Buy
+7,030
New +$275K 0.81% 18
2024
Q2 		– Sell
-7,856
Closed -$253K – 714
2024
Q1 		$253K Buy
+7,856
New +$233K 0.09% 328

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Corton Capital's RVMD Position: Q3 2025 in Review

Corton Capital opened a new position in Revolution Medicines (RVMD) in Q3 2025: 7,030 shares worth $328K. The stake represents 0.81% of the portfolio and ranks #18 among its holdings. This is a return to the name: Corton Capital previously reported a position in RVMD as recently as Q1 2024.

Corton Capital first reported a position in RVMD in Q1 2024 and has held it in 2 quarters since. 323 funds tracked by Wall St. Rank hold RVMD as of Q3 2025.

  • Corton Capital held 7,030 shares of Revolution Medicines worth $328K as of Q3 2025.
  • Revolution Medicines was a new Corton Capital position in Q3 2025.
  • Revolution Medicines made up 0.81% of Corton Capital's portfolio in Q3 2025, its #18 holding.
  • Corton Capital first reported a position in Revolution Medicines in Q1 2024 and has held it in 2 quarters since.
  • 323 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2025.

Based on Corton Capital's 13F filing for Q3 2025, filed 14 Nov 2025.